Literature DB >> 15370936

Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.

Robert J Williams1, Leslie A Goodale, Michele A Shay-Fiddler, Susan P Gloster, Samuel Y Chang.   

Abstract

The prevalence of methylphenidate and dextroamphetamine misuse and abuse was examined in 450 adolescents referred for substance abuse treatment. Twenty three percent reported nonmedical use of these substances and six percent were diagnosed as methylphenidate or dextroamphetamine abusers. Abuse was more common in individuals who were out of school and had an eating disorder. Methylphenidate and dextroamphetamine abuse appears to be much less common than abuse of most other substances. It does occur, however, and parents and schools need to exert greater control over the dispensing of these medications. Physicians are advised to prescribe non-stimulant medications (eg, bupropion) when treating attention deficit hyperactivity disorder in substance-abusing individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370936     DOI: 10.1080/10550490490483053

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  15 in total

1.  Nonmedical use and abuse of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders: patterns, user characteristics, and management options.

Authors:  Meredith Y Smith; George Woody
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 2.  Nonmedical use of prescription stimulants among students.

Authors:  Amelia M Arria; Eric D Wish
Journal:  Pediatr Ann       Date:  2006-08       Impact factor: 1.132

3.  Prevalence of methylphenidate use among Israeli children: 1998-2004.

Authors:  Shlomo Vinker; Rina Vinker; Asher Elhayany
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

4.  Neuroprotective effects of various doses of topiramate against methylphenidate-induced oxidative stress and inflammation in isolated rat amygdala: the possible role of CREB/BDNF signaling pathway.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Reza Falak; Mansour Heidari; Mahshid Sharzad; Elham Kalantari
Journal:  J Neural Transm (Vienna)       Date:  2016-09-24       Impact factor: 3.575

Review 5.  Treatment strategies for co-occurring ADHD and substance use disorders.

Authors:  John J Mariani; Frances R Levin
Journal:  Am J Addict       Date:  2007

6.  An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.

Authors:  Scott H Kollins; Erin N Schoenfelder; Joseph S English; Alex Holdaway; Elizabeth Van Voorhees; Benjamin R O'Brien; Rachel Dew; Allan K Chrisman
Journal:  J Subst Abuse Treat       Date:  2014-08-07

7.  Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: implications for treatment and the role of the primary care physician.

Authors:  Himanshu P Upadhyaya
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

8.  Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use.

Authors:  Amelia M Arria; Kimberly M Caldeira; Kevin E O'Grady; Kathryn B Vincent; Erin P Johnson; Eric D Wish
Journal:  Pharmacotherapy       Date:  2008-02       Impact factor: 4.705

Review 9.  Treatment for Substance Use Disorder With Co-Occurring Mental Illness.

Authors:  Muhammad N Iqbal; Charles J Levin; Frances R Levin
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-04-10

10.  Short-acting versus Long-acting Medications for the Treatment of ADHD.

Authors:  Elisa Cascade; Amir H Kalali; Richard H Weisler
Journal:  Psychiatry (Edgmont)       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.